NDC 80425-0119-01 - Duloxetine DR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0119
- Requested NDC
- 80425-0119-01
- Package NDCs from labels
- 80425-0119-1, 80425-0119-2, 80425-0119-3, 80425-0119-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Duloxetine DR - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0119-1 | DuloxetineDR | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | 8 | |
| 80425-0119-2 | DuloxetineDR | 60 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 60 | 8 | |
| 80425-0119-3 | DuloxetineDR | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0119 | DULOXETINE DR (DULOXETINE) CAPSULE, DELAYED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250101_b70035d4-5a3f-c5b5-e053-2995a90acac1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0119-1 | EA - Each | 80425-0119 | d3634664-507c-4d01-bf7a-4c68186a7538 | 1 | 2023-04-07 |
| 80425-0119-2 | EA - Each | 80425-0119 | 1cfa181c-4e3e-4641-896f-535e5f43d670 | 1 | 2023-04-07 |
| 80425-0119-3 | EA - Each | 80425-0119 | daa7166e-9c7a-4811-9615-9e11ce198d73 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Duloxetine | DULOXETINE | Proficient Rx LP | e36a6919-568a-4d4a-9920-7a7fe4f3441c | 2022-07-01 | Boxed warning, Warnings, Adverse reactions | ANDA208706 596934 9044SC542W |
| Duloxetine | DULOXETINE | Proficient Rx LP | 39bb9e78-e550-4bf9-ba6a-b4d9c7beaeb7 | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | ANDA208706 596930 9044SC542W |
| Duloxetine | DULOXETINE | Sun Pharmaceutical Industries, Inc. | f16beb64-5878-486a-82ee-8e83e728f26c | 2021-11-08 | Boxed warning, Warnings, Adverse reactions | 596926 596930 596934 9044SC542W |
| Duloxetine | DULOXETINE HYDROCHLORIDE | Proficient Rx LP | 51c342c9-b9c6-467d-8fea-b73d72e3febc | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 596934 9044SC542W |
| Duloxetine | DULOXETINE HYDROCHLORIDE | Proficient Rx LP | c34f6115-f447-450f-8c83-58f3c51a76c9 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 596930 9044SC542W |
| Duloxetine | DULOXETINE | Proficient Rx LP | d0a48dfd-af34-470b-9e1f-7678203e9ae5 | 2020-05-01 | Boxed warning, Warnings, Adverse reactions | 596930 9044SC542W |
| Duloxetine | DULOXETINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | b102b8e6-d58f-419c-bb35-720bafa13294 | 2020-03-17 | Boxed warning, Warnings, Adverse reactions | 596926 596930 9044SC542W |
| DULOXETINE DELAYED-RELEASE | DULOXETINE HYDROCHLORIDE | Proficient Rx LP | 407b62b9-5b32-4bac-a2b0-7df499279248 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 596926 9044SC542W |
| Duloxetine Delayed-Release | DULOXETINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | db686a0a-9b2a-4017-8bd1-b981da47c2f3 | 2019-01-11 | Boxed warning, Warnings, Adverse reactions | 596930 9044SC542W |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.